Results of CRS and Debulking in PMP Patients

Uppsala University

Overview

The aim of this study was to compare debulking surgery and cytoreductive surgery in patients with Pseudomyxoma Peritonei with respect to efficacy and safety.

Study Type

OBSERVATIONAL

Conditions

Pseudomyxoma Peritonei

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with radiology histopathology finding of Pseudomyxoma Peritonei Exclusion Criteria: * Preformance status WHO \>2 and histopathology shows other origin then Pseudomyxoma Peritonei

Outcomes

Primary Outcomes

Overall survival

from treatment and forward

Secondary Outcomes

morbidity and mortality

mortality is messured during the first 90 postoperative days and morbidity during hospital stay.

Time frame: 90 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.